R W Tindle - JoVE Visualize

Showing results (21-30 of 39) with videos related to

Pageof 4

Sort By:

Pathology|January 22, 2000

Capture ElISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital wartsS Peng, Y Qi, N Christensen, et al.

Virology|April 28, 1997

E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 proteinK Herd, G J Fernando, L A Dunn, et al.

Archives of Virology|September 11, 1999

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-regionM Street, K Herd, P Londono, et al.

Virology|May 1, 1994

Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised miceR W Tindle, K Herd, P Londoño, et al.

Clinical and Experimental Immunology|August 1, 1995

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvantsR W Tindle, S Croft, K Herd, et al.

Vaccine|January 1, 1995

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a productionG J Fernando, D J Stenzel, R W Tindle, et al.

Cancer Research|June 13, 2000

Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunizationT Doan, K A Herd, P F Lambert, et al.

Vaccine|April 1, 1996

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigenL P Londoño, S Chatfield, R W Tindle, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1990

Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame proteinL A Selvey, R W Tindle, H M Geysen, et al.

Journal of Virology|June 8, 2001

Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoterR W Tindle, K Herd, T Doan, et al.

Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:

Pageof 4

Pathology|January 22, 2000

Capture ElISA and in vitro cell binding assay for the detection of antibodies to human papillomavirus type 6b virus-like particles in patients with anogenital wartsS Peng, Y Qi, N Christensen, et al.

Virology|April 28, 1997

E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 proteinK Herd, G J Fernando, L A Dunn, et al.

Archives of Virology|September 11, 1999

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-regionM Street, K Herd, P Londono, et al.

Virology|May 1, 1994

Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised miceR W Tindle, K Herd, P Londoño, et al.

Clinical and Experimental Immunology|August 1, 1995

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvantsR W Tindle, S Croft, K Herd, et al.

Vaccine|January 1, 1995

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a productionG J Fernando, D J Stenzel, R W Tindle, et al.

Cancer Research|June 13, 2000

Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunizationT Doan, K A Herd, P F Lambert, et al.

Vaccine|April 1, 1996

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigenL P Londoño, S Chatfield, R W Tindle, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1990

Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame proteinL A Selvey, R W Tindle, H M Geysen, et al.

Journal of Virology|June 8, 2001

Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoterR W Tindle, K Herd, T Doan, et al.

Pageof 4